Dr. Vikram Arya is a Senior Staff Fellow in the Office of Clinical Pharmacology (OCP), Center for Drug Evaluation and Research (CDER), FDA. He is primarily responsible for reviewing the clinical pharmacology aspects of regulatory submissions and contributing to the benefit/risk assessment of antiviral drugs. He is an active member of guidance development working groups and OCP Scientific Interest Group (SIG) on drug transporters. He has published articles on antiretroviral drug-drug interactions and impact of transporter modulation on drug disposition and has presented at various national and international conferences. He is a Fellow of the American College of Clinical Pharmacology (ACCP) and serves on the Board of Regents in ACCP. He holds an Adjunct Clinical Professor appointment in the Department of Pharmacy Practice at Mercer University, Atlanta, GA, Adjunct Assistant Professor appointment in the Department of Pharmaceutical Sciences at the University of Tennessee, and Adjunct Associate Professor appointment in the Department of Pharmaceutics, University of Florida. He serves on the Editorial Board of the Journal of Clinical Pharmacology (JCP) and International Journal of Clinical Pharmacology and Therapeutics (IJCPT).